During the past decade, Hirosaki University Hospital conducted 39 clinical trials. In the 10-year time frame, 39 clinical trials started and 16 clinical trials were completed, i.e. on average, 41% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 13 clinical trials were completed. i.e. 72.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hirosaki University Hospital" #1 sponsor was "Janssen Research & Development, LLC" with 6 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "Daiichi Sankyo Co., Ltd." with 3 trials sponsored, "Medtronic Cardiac Rhythm and Heart Failure" with 3 trials sponsored and "Takeda" with 3 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hirosaki University Hospital" #1 collaborator was "Boehringer Ingelheim" with 2 trials as a collaborator, "Japan Lung Cancer Society" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator and "Japan Agency for Medical Research and Development" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Hirosaki University Hospital" are "Atrial Fibrillation" (4 trials), "Heart Failure" (4 trials), "Prostatic Neoplasms" (3 trials), "Breast Neoplasms" (2 trials) and "Colitis, Ulcerative" (2 trials). Many other conditions were trialed in "Hirosaki University Hospital" in a lesser frequency.

Most popular intervention types in "Hirosaki University Hospital" are "Drug" (31 trials), "Device" (8 trials), "Other" (3 trials), "Biological" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Carboplatin" (4 trials), "Atezolizumab" (3 trials), "Gemcitabine" (3 trials) and "Guselkumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Hirosaki University Hospital" are 34 trials for "All" genders, 5 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Hirosaki University Hospital". undefined are not yet recruiting, 13 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Hirosaki University Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hirosaki University Hospital, 0 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 5 trials that are defined as “Not Applicable".

Hirosaki University Hospital has several departments that took part in Clinical trials: "Hirosaki University School of Medicine & Hospital; Urology" - 2 trials